Oncolytics Biotech ONCY
NASDAQ ONCY
$0.77 -0.02 (-2.93%)
As of: Sep 10, 2026 · 3:59 PM EDT

Oncolytics Biotech (ONCY) Divestments (2009 - 2010)

Oncolytics Biotech's (ONCY) quarterly Divestments came in at -$1.9 million in Q3 2010, down 146212.3% year-over-year from N/an in Q3 2009, and down 6166.21% quarter-over-quarter from $31958.0 in Q2 2010.

Analysis

Oncolytics Biotech (ONCY) Divestments (2009 - 2010) Analysis & Trends

Oncolytics Biotech (ONCY) has reported Divestments for 2 consecutive years, with -$1.9 million the latest figure, recorded in Q3 2010.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Oncolytics Biotech 91.92 Mn 91.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 -1.94 Mn
Jun 30, 2010 31,958.00
Sep 30, 2009 -1,325.00
Jun 30, 2009 1.93 Mn